Controlled Release of Doxorubicin from Doxorubicin/<svg style="vertical-align:-4.698pt;width:11.35px;" id="M1" height="16.012501" version="1.1" viewBox="0 0 11.35 16.012501" width="11.35" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/2000/svg"><g transform="matrix(.022,-0,0,-.022,.062,10.1)"><path id="x1D6FE" d="M478 372q0 -39 -31 -97t-61 -98t-78 -98q-45 -55 -73 -102q-13 -79 -13 -197q-11 -11 -43.5 -25.5t-53.5 -15.5l-15 17q5 35 26 101.5t47 123.5q8 72 -1.5 174.5t-37.5 178.5q-14 37 -29 37q-20 0 -67 -65l-25 21q37 60 73 90.5t63 30.5q47 0 72 -112q13 -56 17.5 -141.5
t0.5 -143.5h2q155 193 155 297q0 26 -12 47q-5 8 -5 15q0 16 12.5 27t29.5 11q21 0 34 -21t13 -55z" /></g></svg>-Polyglutamic Acid Ionic Complex

<table>Chemical structures of (a) <svg height="9.9375" id="M15" style="vertical-align:-2.34499pt" version="1.1" viewbox="0 0 8.0625 9.9375" width="8.0625" xmlns="http://www.w3.org/2000/svg">
<g transform="matrix(1.25,0,0,-1.25,0,9.9375)">
<g transform="translate(72,-64.05)">
<text transform="matrix(1,0,0,-1,-71.95,66.44)">
<tspan style="font-size: 12.50px; " x="0" y="0">𝛾</tspan>
</text>
</g>
</g>
</svg>-Polyglutamic Acid and (b) Doxorubicin. In (b), <svg height="11.525" id="M16" style="vertical-align:-0.0pt" version="1.1" viewbox="0 0 6.4749999 11.525" width="6.4749999" xmlns="http://www.w3.org/2000/svg">
<g transform="matrix(1.25,0,0,-1.25,0,11.525)">
<g transform="translate(72,-62.78)">
<text transform="matrix(1,0,0,-1,-71.95,67.83)">
<tspan style="font-size: 8.75px; " x="0" y="0">∗</tspan>
</text>
</g>
</g>
</svg>Deprotonable functional group, <svg height="11.525" id="M17" style="vertical-align:-0.0pt" version="1.1" viewbox="0 0 12.1875 11.525" width="12.1875" xmlns="http://www.w3.org/2000/svg">
<g transform="matrix(1.25,0,0,-1.25,0,11.525)">
<g transform="translate(72,-62.78)">
<text transform="matrix(1,0,0,-1,-71.95,67.83)">
<tspan style="font-size: 8.75px; " x="0" y="0">∗</tspan>
<tspan style="font-size: 8.75px; " x="4.5772958" y="0">∗</tspan>
</text>
</g>
</g>
</svg>Protonable functional group.</table>

Journal of Nanomaterials

fig1

Figure 1

Figure 1: Controlled Release of Doxorubicin from Doxorubicin/<svg style="vertical-align:-4.698pt;width:11.35px;" id="M1" height="16.012501" version="1.1" viewBox="0 0 11.35 16.012501" width="11.35" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/2000/svg"><g transform="matrix(.022,-0,0,-.022,.062,10.1)"><path id="x1D6FE" d="M478 372q0 -39 -31 -97t-61 -98t-78 -98q-45 -55 -73 -102q-13 -79 -13 -197q-11 -11 -43.5 -25.5t-53.5 -15.5l-15 17q5 35 26 101.5t47 123.5q8 72 -1.5 174.5t-37.5 178.5q-14 37 -29 37q-20 0 -67 -65l-25 21q37 60 73 90.5t63 30.5q47 0 72 -112q13 -56 17.5 -141.5
t0.5 -143.5h2q155 193 155 297q0 26 -12 47q-5 8 -5 15q0 16 12.5 27t29.5 11q21 0 34 -21t13 -55z" /></g></svg>-Polyglutamic Acid Ionic Complex 

Journal of Nanomaterials

Controlled Release of Doxorubicin from Doxorubicin/-Polyglutamic Acid Ionic Complex

Figure 1